Sponsor pipeline

Nathan Denlinger clinical trial pipeline

Get alerts when Nathan Denlinger's trials change

2 active trials 2 recruiting 3 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1
NCT07676877 Lymphodepletion With Low Dose Total Body Irradiation Before Standard of Care… Recurrent Diffuse Large B-Cell Lymphoma Recruiting 2026-10-09
NCT06209619 CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma B-Cell Non-Hodgkin Lymphoma-Recurrent Recruiting 2026-02-27

Disease areas by active trials

DLBCL (2) · Non-Hodgkin Lymphoma (2) · Follicular Lymphoma (1)

Get alerts when Nathan Denlinger's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free